Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

KRM Ayurveda IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size 56.67 Cr
Profile
Price Range 128  to  135 per share
Profile
Min Investment ₹135
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Our Company, established in 2019, is operating a network of hospitals and clinics across multiple cities in India aswell as marked its presence in abroad through telemedicines consulting and sales. We integrate authentic Ayurvedicwisdom with modern practices to address chronic, lifestyle, and preventive health needs through personalized careand wellness programs. Presently, Company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in thecountry. Though KRM Ayurveda started off as a kidney hospital and it continues to provide specialized treatmentfor kidney disorders, the Company has widened its horizons in the past few years and has now evolved for varioushealth disorders such as kidney disorder, Liver Cirrhosis, Diabetes, Fatty Liver, Arthritis etc. Company has markedits reach globally as well through Tele-Consultancy Services. Our hospitals and clinics offer a comprehensive rangeof services, including:• In-Patient & Out-Patient Care: Treatment for chronic diseases, lifestyle disorders, and post-operativerehabilitation.• Panchakarma Therapies: Detoxification and rejuvenation programs.• Specialized Clinics: Orthopedic care, skin and hair care, women’s wellness, geriatric care.• Wellness Packages: Stress management, weight management, preventive health plans.• Medicinal Sales: Dispensary of in-house and certified Ayurvedic medicines.• Diet & Lifestyle Counseling: Personalized nutrition and yoga consultation. Read More

Basic Info

Face Value 10 per share

Price 128  to  135 per share

P/E (x) 16.7

Sales( Cr.) 77

PAT( Cr.) 12

EPS 8.1

Draft Prospectus

Exchange NSE-SME

Promoter

Company Promoters

Puneet Dhawan Tanya Dhawan

Pre Issue Share Holding 92.15%

Post Issue Share Holding 67.28%

Listing Details:

Listing Price: 172.1

Listing Gain: 21.56%

Current Price: 261

Gain On Issue: 261 | 0%

GMP: 22.5

GMP %: 16.7 %

IPO Tentative Timetable

Opening Date Jan 21, 2026
Closing Date Jan 23, 2026
Allotment Jan 26, 2026
Refund Jan 27, 2026
Delivery of Shares Jan 27, 2026
Listing Date Jan 28, 2026

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 2000 270,000
Retail (Max) -- -- --
S-HNI (Min) 1 2000 270,000
S-HNI (Max) 3 6000 810,000
B-HNI (Min) 4 8000 1,080,000

Objective of the Issue

1. Capital Expenditure for Construction and Development of Telemedicine Operational Facilities 2. Purchase of CRM Software and Hardware Infrastructure 3. Human Resources 4. Repayment/Prepayment of loan 5. To meet out the Working Capital requirements of the Company and6. To meet out the General Corporate Purposes

Issue

Category Nos Bid Bid (x)
QIB 0 65338000 0x
NII 0 106159000 0x
Retail 0 98222000 0x
EMP 0 0 0x
Total 0 269719000 0x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

KRM Ayurveda Profit & Loss

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 89 67 77
Other Income 0 0 0
Total Income 89 68 77
Total Expenditure 78 60 57
Operating Profit 11 8 20
Interest 1 2 2
Depreciation 1 1 1
Exceptional Income / Expenses 0 0 0
Profit Before Tax 10 5 16
Provision for Tax 2 1 4
Profit After Tax 8 3 12
Adjustments 0 0 0
Profit After Adjustments 8 3 12
Adjusted Earnings Per Share 5.1 2.3 8.1

KRM Ayurveda Balance Sheet

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 8 12 24
Minority's Interest 0 0 0
Borrowings 18 21 19
Other Non-Current Liabilities 0 0 1
Total Current Liabilities 13 11 24
Total Liabilities 39 44 67
Fixed Assets 23 23 27
Other Non-Current Assets 0 0 1
Total Current Assets 16 21 39
Total Assets 39 44 67

KRM Ayurveda Cash Flow

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 0 1
Cash Flow from Operating Activities 4 -1 -0
Cash Flow from Investing Activities -23 -0 -4
Cash Flow from Financing Activities 19 1 6
Net Cash Inflow / Outflow 0 0 2
Closing Cash & Cash Equivalent 1 1 2

KRM Ayurveda Ratios

# Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 5.07 2.27 8.06
CEPS(Rs) 5.49 2.95 8.76
DPS(Rs) 0 0 0
Book NAV/Share(Rs) 5.58 7.85 15.92
Core EBITDA Margin(%) 12.53 11.33 25.44
EBIT Margin(%) 11.91 10.43 24.6
Pre Tax Margin(%) 11.3 7.04 21.34
PAT Margin (%) 8.51 5.08 15.8
Cash Profit Margin (%) 9.23 6.6 17.17
ROA(%) 19.26 8.19 21.86
ROE(%) 90.82 33.88 67.86
ROCE(%) 37.67 22.17 41.83
Receivable days 31.72 36.13 42.11
Inventory Days 2.76 5.77 21.8
Payable days 100.32 163.45 176.74
PER(x) 0 0 0
Price/Book(x) 0 0 0
Dividend Yield(%) 0 0 0
EV/Net Sales(x) 0.22 0.34 0.38
EV/Core EBITDA(x) 1.75 2.84 1.47
Net Sales Growth(%) 0 -24.79 13.99
EBIT Growth(%) 0 -34.15 168.79
PAT Growth(%) 0 -55.09 254.53
EPS Growth(%) 0 -55.09 254.53
Debt/Equity(x) 2.38 1.97 1.31
Current Ratio(x) 1.18 1.84 1.66
Quick Ratio(x) 1.13 1.71 1.33
Interest Cover(x) 19.26 3.07 7.56
Total Debt/Mcap(x) 0 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 15% 0% 0% 0%
Operating Profit CAGR 150% 0% 0% 0%
PAT CAGR 300% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 68% 64% 64% 64%
ROCE Average 42% 34% 34% 34%

Company Contact Information

KRM Ayurveda Ltd.

Pooja Garg

+91- 9289101700

compliance@krmayurveda.com

A-16, G T Karnal Road Industrial Area North West

IPO Lead Manager(s)

KRM Ayurveda Ltd.

Nexgen Financial Solution Pvt Ltd.

Registrar Info

KRM Ayurveda Ltd.

Skyline Financial Services Pvt Ltd

123 , Vinoba Puri,Lajpat Nagar - II,New Delhi

011-26847136/26833777

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!